Human Genome Sciences Submits Biologics License Application to FDA for ABthrax
...that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclonal antibody drug ABthrax (raxibacumab) for the treatment of inhalation anthrax. The BLA submission includes the results of two randomized placebo-controlled studies conducted...
New Drug Applications (FDA) · More like this

Human Genome Sciences Receives Complete Response Letter from FDA for Raxibacumab Biologics License Application
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 16, 2009 - Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has received a Complete Response Letter...
New Drug Applications (FDA) · More like this

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.